Giulia Bandini, Alessia Alunno, Filipe O Pinheiro, Corrado Campochiaro, Ilaria Galetti, Pietro Matucci-Cerinic, Barbara Ruaro, Khadija El Aoufy, Maria R Melis, Alberto Moggi Pignone, Silvia Bellando Randone, Lorenzo Dagna, Marco Matucci-Cerinic, Zsuzsanna H McMahan, Michael Hughes
OBJECTIVE: Proton pump inhibitors (PPIs) are widely prescribed to treat gastroesophageal reflux disease (GERD) in Systemic Sclerosis (SSc). However, not all patients adequately respond to the treatment, and there are frequent concerns about the safety of long-term use of PPIs. Our aim was to identify the main problems/complaints of SSc patients on PPIs, as well as understand their unmet needs. METHODS: SSc patients treated with PPIs were invited through international patient associations and social media to participate in an online survey...
December 18, 2023: Arthritis Care & Research